Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.17 (
PCE
)
1,301
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Studies on
caffeine
consumption have shown a negative correlation with development of some diseases with subsequent beneficial manifestations. Our aim was to assess the effects of
caffeine
on peripheral blood and neural tissue DNA in young adult and aged mice. Male Swiss mice (age 2-3 or 16-18 months, respectively) were treated with a
caffeine
solution (0.3 g/l) for 4 weeks, while controls received water. After the treatments, blood and hippocampal cells (for a comet assay) and femurs (for a micronucleus [MN] test) were collected. The comet assay of peripheral blood and hippocampal cells demonstrated no significant differences between
caffeine
-treated and control young adult mice in terms of DNA damage index (DI) and frequency. In contrast, when comparing young adult with aged animals, significant differences were observed in DNA damage in blood and hippocampal cells. The differences between aged animals (with or without
caffeine
) consisted of a significant decrease in DNA DI in the group that received
caffeine
. In the MN test, an increase in frequency of micronucleated polychromatic (
PCE
) erythrocytes was noted in aged animals that received water compared to young adult mice. In addition, comparing treated with control aged murine groups, a decrease in frequency of MN was found in
PCE
erythrocytes of
caffeine
-treated mice. Chronic
caffeine
consumption was neither genotoxic nor mutagenic at the dose tested; however, it appears that
caffeine
actually protected mice from genotoxicity and mutagenicity, consequences attributed to aging.
...
PMID:A reduction in DNA damage in neural tissue and peripheral blood of old mice treated with caffeine. 2852 28